The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia
Abstract
Rationale Hyponatremia and dexamethasone resistance in polydipsic schizophrenic patients are attributable to changes in hippocampal-modulated antidiuretic and stress hormone activity, respectively. The relationship of the neuroendocrine findings to the psychiatric illness, however, is unknown. An impaired ability to identify facial emotions has been linked to core features of schizophrenia and to diminished levels of the closely related hormone, oxytocin, in the polydipsic subset. Intranasal oxytocin enhances facial affect discrimination in healthy subjects.Objective The aim of this study is to explore if oxytocin reverses impaired facial affect discrimination in schizophrenic patients with, relative to that in patients without, polydipsia.Methods Intranasal oxytocin (10 or 20 IU) and placebo were administered on three occasions to five polydipsic schizophrenic patients, eight nonpolydipsic patients, and 11 healthy controls. Subsequently, subjects rated the presence and intensity of six facial emotions.Results Emotion recognition fell in both patient groups following 10 IU of oxytocin due to an increased propensity to identify all emotions regardless of whether they were displayed. By contrast, emotion recognition improved following 20 IU in polydipsic relative to nonpolydipsic patients due primarily to divergent effects on the bias to identify fear in nonfearful faces.Conclusion The effects of 20 IU oxytocin support the hypothesis that altered neuroendocrine function in polydipsic patients contributes to their psychiatric illness. Further studies are warranted to confirm these findings and assess if oxytocin treatment improves social functioning in this subset. This is the first psychopharmacologic study to compare different doses of oxytocin in the same subject, thus the significance of the opposing responses is unclear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies that have controlled for dose show important dose-dependent variation on physiology (Cardoso et al., 2013) or social cognition (Goldman et al., 2011; Hall et al., 2012).”
From Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review (2014) · cites this paper as Goldman et al., 2011
In the citing paper
“Middle doses (20–24 IU) have the greatest positive effects, whereas low (10 IU) or high doses (48 IU) show blunted effects (Goldman et al., 2011; Hall et al., 2012; Cardoso et al., 2013).”
From Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review (2014) · cites this paper as Goldman et al., 2011
In the citing paper
“In schizophrenic patients, intranasal OT increased emotion recognition at one dose (20 IU) and decreased emotion recognition at a different dose (10 IU) (23).”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [23]
In the citing paper
“A clinical study with divergent single-dose oxytocin administration in patients with schizophrenia showed that 20 IU oxytocin, but not 10 IU oxytocin, ameliorated emotion recognition deficits in a polydipsic group.18”
From Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial (2016) · cites this paper as [18]
In the citing paper
“Only a few studies examined the differential effects of higher (24, 40 or 48 IU) and lower (10, 20 or 24 IU, respectively) oxytocin doses [103-105].”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
In the citing paper
“In these studies the dose around 20 IU (24 IU or 20 IU) had more favorable effects compared to the other dose studied (48, 40 or 10 IU).”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
In the citing paper
“However, these studies were single administration studies on non-clinical outcome measures.”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
Citations
Cites
Baron‐Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00715 · Cited by 4,555 · cited 1×
“Pictures were a subset from Ekman and Friesen (1976) previously used to demonstrate altered responses in facial affect discrimination in patients with amygdala pathology (Adolphs et al. 1999), autism ( Baron-Cohen et al. 2001 ), and schizophrenia (Addington et al. 2006).”
MethodEkman, P. (1976) · Medical Entomology and Zoology · Cited by 4,345
Baron‐Cohen, S., Wheelwright, S. J., Hill, J., Raste, Y., & Plumb, I. (2001) · PubMed · Cited by 4,313
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Neuroendocrine perspectives on social attachment and love
Sue Carter, C. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00055-9 · Cited by 1,425
Oxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298
Contributions to Neuropsychological Assessment
Sarazin, F. (1996) · Europe PMC (PubMed Central) · Cited by 1,151
Facial Emotion Perception in Schizophrenia: A Meta-analytic Review
Kohler, C. G., Walker, J. B., Martin, E. A., Healey, K. M., & Moberg, P. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn192 · Cited by 991
Contributions to Neuropsychological Assessment
Greene, J. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.346 · Cited by 825
Research works printed but not linked: 1
- Targowla R (1923) Des troubles fonctionnel du rein dans les maladies mentales. L’excretion del’eau (Kidney malfunction and mental illness: water excretion). Bull Mém Soc Méd Hôp Paris 47:1711–1715
Cited by
Sorted by citations
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
Is oxytocin “nature’s medicine”
Carter, C. S., Kenkel, W. M., MacLean, E. L., Wilson, S. R., Perkeybile, A. M., Yee, J. R., Ferris, C. F., Nazarloo, H. P., Porges, S. W., Davis, J. M., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019398 · Cited by 394
Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.34 · Cited by 383
Shahrestani, S., Kemp, A. H., & Guastella, A. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.86 · Cited by 283
Cochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0b013e3182a75b7d · Cited by 267
Bales, K. L., Perkeybile, A. M., Conley, O. G., Lee, M. H., Guoynes, C. D., Downing, G. M., Yun, C. R., Solomon, M., Jacob, S., & Mendoza, S. P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.025 · Cited by 265
Kinetics and dose dependency of intranasal oxytocin effects on amygdala reactivity
Spengler, F. B., Schultz, J., Scheele, D., Essel, M., Maier, W., Heinrichs, M., & Hurlemann, R. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.04.015 · Cited by 229
Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study
Cardoso, C., Ellenbogen, M. A., Orlando, M. A., Bacon, S. L., & Joober, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.013 · Cited by 187
Crockford, C., Deschner, T., Ziegler, T. E., & Wittig, R. M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00068 · Cited by 187
Developmental Perspectives on Oxytocin and Vasopressin
Hammock, E. A. D. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.120 · Cited by 184
MacDonald, K., & Feifel, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00035 · Cited by 181
Intranasal administration of oxytocin: behavioral and clinical effects, a review
Veening, J. G., & Olivier, B. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.012 · Cited by 169
The Oxytocin–Vasopressin Pathway in the Context of Love and Fear
Carter, C. S. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00356 · Cited by 170
Oxytocin-Augmented Social Cognitive Skills Training in Schizophrenia
Davis, M. C., Green, M. F., Lee, J., Horan, W. P., Senturk, D., Clarke, A. D., & Marder, S. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.68 · Cited by 149
Yamasue, H., Yee, J. R., Hurlemann, R., Rilling, J. K., Chen, F. S., Meyer-Lindenberg, A., & Tost, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3327-12.2012 · Cited by 149
Blevins, J. E., & Baskin, D. G. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.05.023 · Cited by 135
Long-term exposure to intranasal oxytocin in a mouse autism model
Bales, K. L., Solomon, M., Jacob, S., Crawley, J. N., Silverman, J. L., Larke, R. H., Sahagún, E., Puhger, K. R., Pride, M. C., & Mendoza, S. P. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.117 · Cited by 131
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi-Nazarloo, H., Drogos, L. L., Hill, S. K., Ruocco, A. C., Keedy, S. K., Reilly, J. L., Keshavan, M. S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu027 · Cited by 127
Effects of single dose intranasal oxytocin on social cognition in schizophrenia
Davis, M. C., Lee, J., Horan, W. P., Clarke, A. D., McGee, M. R., Green, M. F., & Marder, S. R. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.023 · Cited by 124
Montag, C., Brockmann, E.-M., Lehmann, A. I., Müller, D. J., Rujescu, D., & Gallinat, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051882 · Cited by 128
Cacciotti-Saija, C., Langdon, R., Ward, P. B., Hickie, I. B., Scott, E. M., Naismith, S. L., Moore, L., Alvares, G. A., Redoblado Hodge, M. A., & Guastella, A. J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu094 · Cited by 119
Millan, M. J., & Bales, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.012 · Cited by 119
Kosaka, H., Okamoto, Y., Munesue, T., Yamasue, H., Inohara, K., Fujioka, T., Anme, T., Orisaka, M., Ishitobi, M., Jung, M., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.152 · Cited by 117
Oxytocin administration enhances controlled social cognition in patients with schizophrenia
Woolley, J. D., Chuang, B., Lam, O., Lai, W., O’Donovan, A., Rankin, K. P., Mathalon, D. H., & Vinogradov, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.024 · Cited by 116
Oxytocin in schizophrenia: a review of evidence for its therapeutic effects
MacDonald, K. S., & Feifel, D. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00634.x · Cited by 117
A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia
Feifel, D., Shilling, P. D., & MacDonald, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.025 · Cited by 110
Role of oxytocin signaling in the regulation of body weight
Blevins, J. E., & Ho, J. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9260-x · Cited by 108
Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia
Modabbernia, A., Rezaei, F., Salehi, B., Jafarinia, M., Ashrafi, M., Tabrizi, M. H., Hosseini, S. M. R., Tajdini, M., Ghaleiha, A., & Akhondzadeh, S. (2012) · CNS Drugs · doi:10.1007/s40263-012-0022-1 · Cited by 107
Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: A case–control study
Montag, C., Brockmann, E.-M., Bayerl, M., Rujescu, D., Müller, D. J., & Gallinat, J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.677547 · Cited by 105
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders
Romano, A., Tempesta, B., Bonaventura, M. V. M. D., & Gaetani, S. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00497 · Cited by 106
Intranasal oxytocin effects on social cognition: A critique
Evans, S. L., Dal Monte, O., Noble, P., & Averbeck, B. B. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.008 · Cited by 97
Oxytocin and stress-related disorders: neurobiological mechanisms and treatment opportunities
Sippel, L. M., Allington, C. E., Pietrzak, R. H., Harpaz-Rotem, I., Mayes, L. C., & Olff, M. (2017) · Chronic Stress · doi:10.1177/2470547016687996 · Cited by 99
Social cognitive interventions for people with schizophrenia: A systematic review
Tan, B., Lee, S.-A., & Lee, J. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2016.06.013 · Cited by 100
Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia
Rubin, L. H., Carter, C. S., Drogos, L. L., Jamadar, R., Pournajafi‐Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.002 · Cited by 91
Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients
Jobst, A., Dehning, S., Ruf, S., Notz, T., Buchheim, A., Henning-Fast, K., Meißner, D., Meyer, S., Bondy, B., Müller, N., et al. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.20 · Cited by 89
Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward
Bradley, E., & Woolley, J. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.007 · Cited by 92
Gibson, C. M., Penn, D. L., Smedley, K. L., Leserman, J., Elliott, T., & Pedersen, C. A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.009 · Cited by 88
The many faces of oxytocin: Implications for psychiatry
Zik, J. B., & Roberts, D. L. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.048 · Cited by 91
Potential of Oxytocin in the Treatment of Schizophrenia
Shilling, P. D., & Feifel, D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0315-x · Cited by 84
Improving social perception in schizophrenia: The role of oxytocin
Fischer-Shofty, M., Brüne, M., Ebert, A., Shefet, D., Levkovitz, Y., & Shamay‐Tsoory, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.006 · Cited by 83
Inhaled oxytocin increases positive social behaviors in newborn macaques
Simpson, E. A., Sclafani, V., Paukner, A., Hamel, A. F., Novak, M. A., Meyer, J. S., Suomi, S. J., & Ferrari, P. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402471111 · Cited by 82
Oxytocin enhances attention to the eye region in rhesus monkeys
Dal Monte, O., Noble, P. L., Costa, V. D., & Averbeck, B. B. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00041 · Cited by 80
Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia
Smith, M. J., Horan, W. P., Karpouzian‐Rogers, T., Abram, S. V., Cobia, D. J., & Csernansky, J. G. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.012 · Cited by 81
Bürkner, P., Williams, D. R., Simmons, T. C., & Woolley, J. D. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx053 · Cited by 82
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
Goh, K. K., Chen, C.-H., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042146 · Cited by 84
Peled‐Avron, L., Abu-Akel, A. M., & Shamay‐Tsoory, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.023 · Cited by 79
Oxytocin administration alters HPA reactivity in the context of parent–infant interaction
Weisman, O., Zagoory-Sharon, O., & Feldman, R. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.06.006 · Cited by 70
A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia
Guastella, A. J., Ward, P. B., Hickie, I. B., Shahrestani, S., Hodge, M. A., Scott, E. M., & Langdon, R. A. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.005 · Cited by 69
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi‐Nazarloo, H., Harris, M. S. H., Hill, S. K., Reilly, J. L., & Sweeney, J. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.019 · Cited by 65
Cardoso, C., Linnen, A.-M., Joober, R., & Ellenbogen, M. A. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0025763 · Cited by 60
Frijling, J. L., van Zuiden, M., Koch, S. B., Nawijn, L., Goslings, J. C., Luitse, J. S., Biesheuvel, T. H., Honig, A., Bakker, F. C., Denys, D., et al. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-92 · Cited by 59
A Role for Oxytocin in the Etiology and Treatment of Schizophrenia
Rich, M. E., & Caldwell, H. K. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00090 · Cited by 60
Jarskog, L. F., Pedersen, C. A., Johnson, J. L., Hamer, R. M., Rau, S. W., Elliott, T., & Penn, D. L. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.008 · Cited by 56
Strauss, G. P., Keller, W. R., Koenig, J. I., Gold, J. M., Ossenfort, K. L., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.023 · Cited by 54
Bartholomeusz, C. F., Ganella, E. P., Labuschagne, I., Bousman, C., & Pantelis, C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.007 · Cited by 54
Oxytocin and social cognition in affective and psychotic disorders
Pérez-Rodríguez, M. M., Mahon, K., Russo, M., Ungar, A. K., & Burdick, K. E. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.012 · Cited by 58
Oya, K., Matsuda, Y., Matsunaga, S., Kishi, T., & Iwata, N. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0634-9 · Cited by 52
Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia
Strauss, G. P., Keller, W. R., Koenig, J. I., Gold, J. M., Frost, K. H., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.034 · Cited by 51
Strauss, G. P., Chapman, H. C., Keller, W. R., Koenig, J. I., Gold, J. M., Carpenter, W. T., & Buchanan, R. W. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.02.017 · Cited by 49
Strauss, G. P., Keller, W. R., Koenig, J. I., Sullivan, S. K., Gold, J. M., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.022 · Cited by 46
Bose, M., Quipildor, G. F., Ehrlich, M. E., & Salton, S. R. (2022) · Cells · doi:10.3390/cells11223629 · Cited by 47
Fischer-Shofty, M., Shamay‐Tsoory, S., & Levkovitz, Y. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00127 · Cited by 41
Comparative and developmental perspectives on oxytocin and vasopressin.
Bales, K. L. (2013) · American Psychological Association eBooks · doi:10.1037/14250-002 · Cited by 40
Buchanan, R. W., Kelly, D. L., Weiner, E., Gold, J. M., Strauss, G. P., Koola, M. M., McMahon, R. P., & Carpenter, W. T. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000720 · Cited by 41
Sabé, M., Zhao, N., Crippa, A., Strauss, G. P., & Kaiser, S. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab020 · Cited by 41
The Role of Intranasal Oxytocin in the Treatment of Patients with Schizophrenia: A Systematic Review
Berardis, D. D., Marini, S., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., Mazza, M., Valchera, A., Fornaro, M., Cavuto, M., Srinivasan, V., et al. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312020012 · Cited by 39
Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications
Iovino, M., Messana, T., Tortora, A., Giusti, C., Lisco, G., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200520093730 · Cited by 39
Cardoso, C., Orlando, M. A., Brown, C. A., & Ellenbogen, M. A. (2014) · Social Neuroscience · doi:10.1080/17470919.2013.873079 · Cited by 38
Horta de Macedo, L. R., Zuardi, A. W., Machado-de-Sousa, J. P., Chagas, M. H. N., & Hallak, J. E. C. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.07.082 · Cited by 35
Gumley, A. I., Braehler, C., & MacBeth, A. M. (2014) · British Journal of Clinical Psychology · doi:10.1111/bjc.12041 · Cited by 34
RetractedThe Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders
Okamoto, Y., Ishitobi, M., Wada, Y., & Kosaka, H. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120845 · Cited by 33
Green, M. F., Lee, J., & Ochsner, K. N. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt131 · Cited by 33
Oxytocin and interpersonal relationships
Patin, A., Scheele, D., & Hurlemann, R. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_22 · Cited by 32
Schwartz, S. S., Gallagher, R. J., & Berkson, G. (1986) · PubMed · Cited by 32
Patin, A., & Hurlemann, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_10 · Cited by 37
Oxytozin: Evidenz für ein therapeutisches Potenzial des sozialen Neuromodulators
Eckstein, M., & Hurlemann, R. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3832-6 · Cited by 28
Canty, A. L., Cao, Y., Neumann, D. L., & Shum, D. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113852 · Cited by 26
Oxytocin improves probabilistic reversal learning but not effortful motivation in Brown Norway rats
Roberts, B. Z., Young, J. W., He, Y. V., Cope, Z. A., Shilling, P. D., & Feifel, D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.028 · Cited by 24
Are We There Yet? The Clinical Potential of Intranasal Oxytocin in Psychiatry
Liu, J. C., McErlean, R. A., & Dadds, M. R. (2012) · Current Psychiatry Reviews · doi:10.2174/157340012798994902 · Cited by 25
Strauss, G. P., Granholm, E. L., Holden, J. L., Ruiz, I., Gold, J. M., Kelly, D. L., & Buchanan, R. W. (2018) · Psychological Medicine · doi:10.1017/s0033291718002465 · Cited by 25
Oxytocin and Social Cognitions in Schizophrenia: A Systematic Review
Bukovskaya, O., & Shmukler, A. B. (2015) · Psychiatric Quarterly · doi:10.1007/s11126-015-9407-x · Cited by 24
Skinner, J. A., Garg, M. L., Dayas, C. V., Fenton, S., & Burrows, T. L. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nux078 · Cited by 22
Brain circuit dysfunction in a distinct subset of chronic psychotic patients
Goldman, M. B. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.001 · Cited by 22
Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs
Temesi, A., Thuróczy, J., Balogh, L., & Miklósi, Á. (2017) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00147 · Cited by 19
Nance, M. G., Sullivan, K. M., & Puglia, M. H. (2024) · Pediatric Research · doi:10.1038/s41390-024-03563-z · Cited by 18
Romero‐Martínez, Á., Sarrate‐Costa, C., & Moya‐Albiol, L. (2021) · Biology · doi:10.3390/biology10121334 · Cited by 19
Reproductive experiential regulation of cognitive and emotional resilience
Kinsley, C. H., Bales, K. L., Bardi, M., & Stolzenberg, D. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.015 · Cited by 20
Güzel, D., Yazıcı, A. B., Pek, T. M., Doğanay, S., Saykan, A. B., Sağlam, K., Turan, Ç., & Yazıcı, E. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s169619 · Cited by 16
Marazziti, D., Diep, P.-T., Carter, C. S., & Carbone, M. G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220727120646 · Cited by 16
Oxytocin and Schizophrenia Spectrum Disorders
Ettinger, U., Hurlemann, R., & Chan, R. C. K. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_27 · Cited by 17
Pedersen, C. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.050 · Cited by 11
Spilka, M. J., Keller, W. R., Buchanan, R. W., Gold, J. M., Koenig, J. I., & Strauss, G. P. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13421 · Cited by 13
Exploring a Possible Interplay between Schizophrenia, Oxytocin, and Estrogens: A Narrative Review
Papadea, D., Dalla, C., & Tata, D. Α. (2023) · Brain Sciences · doi:10.3390/brainsci13030461 · Cited by 12
Personality Disorders, Attachment and Psychodynamic Psychotherapy
Weinstein, L., Pérez-Rodríguez, M. M., & Siever, L. J. (2014) · Psychopathology · doi:10.1159/000366135 · Cited by 7
The Use of Oxytocin in Personality Disorders: Rationale and Current Status
Pérez-Rodríguez, M. M., Derish, N. E., & New, A. S. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0026-1 · Cited by 8
Schepisi, C., Cianci, S., Bedse, G., Fu, J., Gaetani, S., & Nencini, P. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3527-0 · Cited by 6
Massey, S. H., Estabrook, R., Lapping-Carr, L. R., Newmark, R. L., Jean Decety, A., Wisner, K. L., & Wakschlag, L. S. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.115071 · Cited by 5
Oxytocin in Prevention of Schizophrenia
Tadjibaev, A. (2013) · International Journal of Prevention and Treatment of Substance Use Disorders · Cited by 4
Heinrichs, M., Chen, F. S., & Domes, G. (2012) · Wiley eBooks · doi:10.1002/9781119945901.ch8 · Cited by 4
Doshi, G., Bhatia, N. Y., Ved, H. S., Pandya, A., Kulkarni, D., Naik, J., Bandiwadekar, T., Godad, A. P., & Kale, P. P. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220817161035 · Cited by 3
Metadata
- Authors
- Goldman, M. B., Gomes, A. M., Carter, C. S., & Lee, R.
- Affiliations
- Northwestern University (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Corresponding author
- Goldman, Morris B.
- Venue
- Psychopharmacology
- Published
- 2011-02-09
- Volume
- 216
- Issue
- 1
- Pages
- 101-110
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2071486937
- Cited by
- 112
- References
- 62
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 11 · 2016: 6 · 2015: 12 · 2014: 24 · 2013: 20 · 2012: 10
- FWCI
- 25.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago
- National Institutes of Health
- National Institute of Mental Health (R21MH082295)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Face Recognition and Perception
- Keywords
- intranasal oxytocin, polydipsia, schizophrenia, facial emotion recognition, dose-dependent effects, hyponatremia, dexamethasone resistance, neuroendocrine dysfunction, vasopressin, stress hormones
- MeSH terms
- Administration, Intranasal, Adult, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Facial Expression, Female, Humans, Male, Middle Aged, Oxytocin, Pilot Projects, Schizophrenia, Schizophrenic Psychology, Thirst, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
